The Food and Drug Administration (FDA) has updated the labeling for Kisunla ™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer ...

Rhythm's bivamelagon cut BMI and hunger scores in Phase 2 trial for hypothalamic obesity, prompting plans to discuss Phase 3 ...

Lilly's Kisunla gets FDA approval for a new dosing schedule that significantly lowers ARIA-E risk while maintaining amyloid ...

For the purposes of this update and the dosing charts, the doses of each inhaled corticosteroid are those approved by the FDA: for metered-dose inhalers (MDIs), the amount of actuated dose that ...

Consequently, combination therapy currently involves the administration of one cholinergic drug (donepezil, galantamine or rivastigmine) and one glutamatergic drug (memantine).

Where the Money Goes: Map, Charts Show Migrant Remittance Payments Published Jun 13, 2025 at 11:26 AM EDT Updated Jun 13, 2025 at 11:30 AM EDT 00:48 ...

UroGen was up nearly 52% when markets closed on Thursday. Zusduri is the company’s second commercial product, following the low-grade upper tract urothelial cancer drug Jelmyto, which was approved in ...

The U.S. Food and Drug Administration on Thursday approved UroGen Pharma's drug to treat a type of bladder cancer, providing an alternative treatment as opposed to traditional surgical procedures.

A pop-up ICE protest on Tucson's southwest side Wednesday, got in the way of a drug bust six months in the making, according to Pinal County Sheriff Ross Teeple.

Yaqoot Fatima receives funding from NHMRC, MRFF, Beyond Blue and in-kind support from ResMed. Nisreen Aouira does not work for, consult, own shares in or receive funding from any company or ...